<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">persmed</journal-id><journal-title-group><journal-title xml:lang="ru">Российский журнал персонализированной медицины</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal for Personalized Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2782-3806</issn><issn pub-type="epub">2782-3814</issn><publisher><publisher-name>ФОНД АЛМАЗОВА</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18705/2782-3806-2024-4-6-531-537</article-id><article-id custom-type="edn" pub-id-type="custom">SYVKHR</article-id><article-id custom-type="elpub" pub-id-type="custom">persmed-299</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ СЛУЧАИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL CASE</subject></subj-group></article-categories><title-group><article-title>Редкая моногенная причина артериальной гипертензии</article-title><trans-title-group xml:lang="en"><trans-title>Rare monogenic cause of arterial hypertension</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Соколенко</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Sokolenko</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Соколенко Анна Вадимовна, студент 6 курса Института медицинского образования</p><p>ул. Аккуратова, д. 2, Санкт-Петербург, 197341</p></bio><bio xml:lang="en"><p>Sokolenko Anna V., student at the Institute of Medical Education</p><p>Akkuratova str., 2, Saint Petersburg, 197341</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Климшина</surname><given-names>Л. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Klimshina</surname><given-names>L. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Климшина Лейла Рамазановна, ассистент кафедры детских болезней с клиникой Института медицинского образования</p><p>ул. Аккуратова, д. 2, Санкт-Петербург, 197341</p></bio><bio xml:lang="en"><p>Klimshina Leila R., Assistant at the Department of Childhood Diseases with Clinic at the Institute of Medical Education</p><p>Akkuratova str., 2, Saint Petersburg, 197341</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Никитина</surname><given-names>И. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikitina</surname><given-names>I. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Никитина Ирина Леоровна, д.м.н., профессор, заведующий кафедрой детских болезней с клиникой Института медицинского образования</p><p>ул. Аккуратова, д. 2, Санкт-Петербург, 197341</p></bio><bio xml:lang="en"><p>Nikitina Irina L., Doctor of Medical Sciences, Professor, Head of the Department of Childhood Diseases with Clinic at the Institute of Medical Education</p><p>Akkuratova str., 2, Saint Petersburg, 197341</p></bio><email xlink:type="simple">nikitina0901@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр имени В. А. Алмазова» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Almazov National Medical Research Centre</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>25</day><month>12</month><year>2024</year></pub-date><volume>4</volume><issue>6</issue><fpage>531</fpage><lpage>537</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Соколенко А.В., Климшина Л.Р., Никитина И.Л., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Соколенко А.В., Климшина Л.Р., Никитина И.Л.</copyright-holder><copyright-holder xml:lang="en">Sokolenko A.V., Klimshina L.R., Nikitina I.L.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://persmed.elpub.ru/jour/article/view/299">https://persmed.elpub.ru/jour/article/view/299</self-uri><abstract><p>Вторичная артериальная гипертензия обладает высокой гетерогенностью причин, уточнение ее этиологии представляет собой ключевой этап в процессе диагностики и лечения. Правильное определение причины гипертензии напрямую влияет на выбор терапевтической тактики и может существенно изменить прогноз для пациента. В ряде случаев для более точного выявления этиологического фактора может потребоваться молекулярно-генетическое исследование. Одной из редких, но значимых причин вторичной артериальной гипертензии является псевдогипоальдостеронизм, который может оставаться недиагностированным в течение длительного времени или быть ошибочно интерпретированным как первичная гипертензия. В данной статье представлен клинический случай пациентки 16 лет с псевдогипоальдостеронизмом IIЕ типа, история которой подчеркивает важность дифференциальной диагностики при выявлении этиологии артериальной гипертензии в детском и подростковом возрасте. В статье представлены основные клинические проявления заболевания, данные лабораторного, инструментального, молекулярно-генетического исследований, которые способствовали установлению диагноза и оптимизации лечения в данном случае.</p></abstract><trans-abstract xml:lang="en"><p>Secondary arterial hypertension is characterized by a diverse range of etiological factors, making the clarification of its underlying causes a fundamental aspect of both diagnosis and treatment. Accurate identification of the etiology of hypertension directly influences therapeutic strategies and has significant implications for patient prognosis. In certain instances, molecular genetic testing may be necessary to pinpoint the specific etiological factor with greater precision. Among the rare but noteworthy causes of secondary arterial hypertension is pseudohypoaldosteronism, which can often remain undiagnosed for prolonged periods or be misclassified as primary hypertension. This article presents the clinical case of a 15-year-old female patient diagnosed with type IIE pseudohypoaldosteronism, emphasizing the critical role of differential diagnosis in managing arterial hypertension in pediatric and adolescent populations. We will explore the principal clinical manifestations of the condition, as well as the laboratory, instrumental, and molecular genetic findings that facilitated the accurate diagnosis and optimization of treatment for this patient.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>артериальная гипертензия</kwd><kwd>гиперальдостеронизм</kwd><kwd>куллин</kwd><kwd>псевдогипоальдостеронизм</kwd><kwd>тиазидные диуретики</kwd><kwd>CUL3</kwd></kwd-group><kwd-group xml:lang="en"><kwd>arterial hypertension</kwd><kwd>Cullin</kwd><kwd>CUL3</kwd><kwd>hyperaldosteronism</kwd><kwd>pseudohypoaldosteronism</kwd><kwd>thiazide diuretics</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Sharma P, Chatrathi HE. Insights into the diverse mechanisms and effects of variant CUL3-induced familial hyperkalemic hypertension. Cell Commun Signal. 2023;21(1):286.</mixed-citation><mixed-citation xml:lang="en">Sharma P, Chatrathi HE. Insights into the diverse mechanisms and effects of variant CUL3-induced familial hyperkalemic hypertension. Cell Commun Signal. 2023;21(1):286.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Hureaux M, Mazurkiewicz S, Boccio V, et al. The variety of genetic defects explains the phenotypic heterogeneity of Familial Hyperkalemic Hypertension. Kidney International Reports. 2021;6(10):2639–52.</mixed-citation><mixed-citation xml:lang="en">Hureaux M, Mazurkiewicz S, Boccio V, et al. The variety of genetic defects explains the phenotypic heterogeneity of Familial Hyperkalemic Hypertension. Kidney International Reports. 2021;6(10):2639–52.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao Y, Schubert H, Blakely A, et al. Structural bases for Na+-Cl− cotransporter inhibition by thiazide diuretic drugs and activation by kinases. Nature Communications. 2024;15(1):7006.</mixed-citation><mixed-citation xml:lang="en">Zhao Y, Schubert H, Blakely A, et al. Structural bases for Na+-Cl− cotransporter inhibition by thiazide diuretic drugs and activation by kinases. Nature Communications. 2024;15(1):7006.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Chatrathi HE, Collins JC, Wolfe LA, et al. Novel CUL3 Variant Causing Familial Hyperkalemic Hypertension Impairs Regulation and Function of Ubiquitin Ligase Activity. Hypertension. 2022;79(1): 60–75.</mixed-citation><mixed-citation xml:lang="en">Chatrathi HE, Collins JC, Wolfe LA, et al. Novel CUL3 Variant Causing Familial Hyperkalemic Hypertension Impairs Regulation and Function of Ubiquitin Ligase Activity. Hypertension. 2022;79(1): 60–75.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Blackburn PR, Ebstein F, Hsieh TC, et al. Loss-of-Function Variants in CUL3 Cause a Syndromic Neurodevelopmental Disorder. Ann Neurol. 2024.</mixed-citation><mixed-citation xml:lang="en">Blackburn PR, Ebstein F, Hsieh TC, et al. Loss-of-Function Variants in CUL3 Cause a Syndromic Neurodevelopmental Disorder. Ann Neurol. 2024.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Zaidi S, Choi M, Wakimoto H, et al. De novo mutations in histone-modifying genes in congenital heart disease. Nature. 2013;498(7453):220–3.</mixed-citation><mixed-citation xml:lang="en">Zaidi S, Choi M, Wakimoto H, et al. De novo mutations in histone-modifying genes in congenital heart disease. Nature. 2013;498(7453):220–3.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Cornelius RJ, Maeoka Y, McCormick JA. Renal effects of cullin 3 mutations causing familial hyperkalemic hypertension. Current opinion in nephrology and hypertension. 2023;32(4):335–43.</mixed-citation><mixed-citation xml:lang="en">Cornelius RJ, Maeoka Y, McCormick JA. Renal effects of cullin 3 mutations causing familial hyperkalemic hypertension. Current opinion in nephrology and hypertension. 2023;32(4):335–43.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Мельниченко Г.А., Платонова Н.М., Бельцевич Д.Г. и др. Первичный гиперальдостеронизм: диагностика и лечение. Новый взгляд на проблему. По материалам Проекта клинических рекомендаций Российской ассоциации эндокринологов по диагностике и лечению первичного гиперальдостеронизма. Consilium Medicum. 2017;19(4):75–85.</mixed-citation><mixed-citation xml:lang="en">Mel`nichenko GA, Platonova NM, Bel`cevich DG, et al. Primary hyperaldosteronism: diagnosis and treatment. A new look at the problem. Based on the materials of the Draft clinical recommendations of the Russian Association of Endocrinologists for the diagnosis and treatment of primary hyperaldosteronism. Consilium Medicum. 2017;19(4):75–85. In Russian.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
